Trails Edge Biotechnology Offshore Fund, LP is a hedge fund based in Atlanta, Georgia. According to its most recent Form D, filed Jun 25, 2026, the fund has sold $292,874,003 of interests to 36 investors since its first sale in Jul 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Trails Edge Biotechnology Fund GP, LP; Trails Edge Capital Partners, LP; Ortav Yehudai.
- Total raised
- $292,874,003Cumulative sales reported on Form D
- Investors
- 36
- First sale
- Jul 1, 2025
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Trails Edge Biotechnology Fund GP, LP; Trails Edge Capital Partners, LP; Ortav Yehudai
- Latest Form D
- Jun 25, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures
Size compared with every hedge fund
Raised more than 87% of the 143 hedge funds based in Georgia, and more than 74% of all 10,157 that report sales.